CapMed: health records are not created equal

Share this article:
Consumer personal health records (PHR) are more than just a storage space for electronic health records.
According to Wendy Angst, general manager at CapMed, a provider of interactive personal health records, there are two major groups of PHRs: tethered and untethered. “The untethered model belongs to the consumer,” explained Angst, compared with the tethered PHR that is tied to a product or an insurance plan.

The untethered, consumer-centric model allows patients to make their own decisions about what kinds of information is included in a PHR, and how it's shared. “The individual [patient] can grant access to all or part of the PHR information,” said Angst. For instance, patients can allow a spouse or a specialist to view specific content—and set limitations. 

“A patient could elect to share just dermatological information, for example,” noted Angst. In addition to medical histories and emergency information, PHRs can be customized to feature FDA updates, drug recalls, adherence reminders and formulary information, said Angst.  

CapMed offers a variety of PHRs that can be delivered online and to mobile phones. Additionally, the company markets a portable USB drive, or Personal HealthKey, that offers patients the ability to carry a PHR with them on a key ring.

CapMed also offers branded PHRs, and has partnered with Kerr Drug and provided software for Microsoft's HealthVault. From an advertising standpoint, Angst said CapMed is able to insert promo materials into PHRs, which could prove valuable in a drug launch. 


Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.